Home | Contact Us | Advertise | About Us | Privacy Policy | News Archive
Medicine Politics Practice Ideas Other stuff Jobs
Search 

Revamp to stem ADR reporting decline

by Michael Woodhead

 

The TGA has launched a revamped ‘blue card’ (link) for reporting adverse reactions in a bid to turn around dwindling rates of reporting by GPs.

 

In the latest edition of the Australian Adverse Drug Reactions Bulletin (link) the TGA says it hopes the new blue card will help maintain Australia’s high ADR reporting rates by global standards.

 

“We have consulted widely about what reporters would like and we hope the new form is easier to fill in. The major change is that the form is bigger,” it says.

 

But under-reporting of drug reactions is still the norm and GPs are said to report only 2% of adverse drug reactions they encounter. Recent figures form the Adverse Drug Reactions Monitoring Unit show that the vast majority of adverse drug reaction reports are now filed by hospitals, drug manufacturers and consumers. The number of reports filed by GPs peaked in 2002 at almost 4000 per year but has since fallen steadily to only about a quarter of that level (link)

 

The Adverse Drug Reactions Advisory Committee says it is also possible to report reactions via the web, fax, email or phone.


4 August 2008
Comment on this article (comments are moderated and may take some time to appear)


Latest Comments

  • It is 2008 and most GPs are prescribing electronically and many are keeping all clinical information electronically. A little blue paper form, Web form or email message, into which we are expected to re-enter the data that we have already sweated to enter into our own clinical systems, is not going to cut it.

    If the TGA was serious about increasing the frequency of reporting of adverse drug reactions, it would have funded the development of a facility that offers to report the details automatically whenever we record in our clinical systems that we have stopped a patient's medication or if we record an adverse reaction to a medication. A small payment of say $10 per report would help to encourage us to push the button to let the report be sent.

    My message to the TGA is: check the calendar and look in through some GPs' windows. Did you know that the Commonwealth is working on a National E-Health Strategy right now?

    Dr Oliver Frank,

    Hampstead Gardens, SA

    Posted by Oliver Frank 5/08/2008 3:49:40 PM

  • It would be very simple to increase reporting rates. Bring back the yellow book and mail it out to every GP every three months, so that they can easily find an adverse reactions reporting form. This is another reason why the Yellow book should be re-introduced, but will those Bureaucrats who made the short sighted decision to abolish the yellow book ever be prepared to admit their mistake?

    Dr John de Vries, Brisbane.

    Posted by Dr John de Vries 5/08/2008 3:50:17 PM

  • It would be trivial to write a daemon which popped up to seek permission and posted the data to the government, whenever certain triggers happened in the database. Since we have read access to all the popular EHRs we wouldn't even need to involve the vendors. All it needs is someone with a clue and experience with these databases. Where do I apply? Why don't these people come to us and try things the easy way for a change?

    Peter Machell, Brisbane

    Posted by Peter Machell 5/08/2008 3:50:41 PM

  • The simplest way to increase drug reporting is to have it built into desktop software. ie patient mentions side effect and we are able to 'click' and report almost instantaneously. A drug adverse reaction is an intense communication issue and to have to turn around and 'fill in a form' is not easy on a busy morning.

    Dr John Parsons, Helensvale Qld.

    Posted by Dr John Parsons 5/08/2008 3:51:11 PM

  • I would recommend the addition of a "serendipity" section in the electronic or card form. I had a patient declare that his psoriasis improved greatly following initiation of questran. I am sure there is nothing to this - the drug is not even absorbed- but if other doctors had noted this and had a mechanism to report it (ADRAC already exists) there may be indication to further investigate incidental fortunate outcomes! Alan Watson GP Highbury South Australia

    Posted by Alan Watson 6/08/2008 4:27:28 PM

Submit your feedback here:

Full name:
Email address:
Email address is used for verification only, we will not publish it.
Your comments:
Security Code:
Change Image

Remember my details

(So you don't have to retype your details each time you send feedback.)

 

From other sites
GPs are the primary maternity carers
Aged care home transfers to ED avoidable
About face on cataract rebates
GPs lack email for discharge summaries
Document library
 
 
Send us an anonymous tip
 






From the publishers of New Scientist & the Lancet